Related Experiment Video
Updated: Apr 28, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Epigenetic alterations in endocrine-related cancer
Sandra Rodríguez-Rodero1, Elías Delgado-Álvarez2, Agustín F Fernández2
1Endocrinology and Nutrition ServiceHospital Universitario Central de Asturias, Av. Julian Clavería s/n, 33006 Oviedo, SpainCancer Epigenetics LaboratoryInstituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, 33006 Oviedo, SpainDepartment of Immunology and OncologyNational Center for Biotechnology, CNB-CSIC, Cantoblanco, Madrid E-28049, SpainEndocrinology and Nutrition ServiceHospital Universitario Central de Asturias, Av. Julian Clavería s/n, 33006 Oviedo, SpainCancer Epigenetics LaboratoryInstituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, 33006 Oviedo, SpainDepartment of Immunology and OncologyNational Center for Biotechnology, CNB-CSIC, Cantoblanco, Madrid E-28049, Spain.
Abstract:
Aberrant epigenetics is a hallmark of cancer, and endocrine-related tumors are no exception. Recent research has been identifying an ever-growing number of epigenetic alterations in both genomic DNA methylation and histone post-translational modification in tumors of the endocrine system. Novel microarray and ultra-deep sequencing technologies have allowed the identification of genome-wide epigenetic patterns in some tumor types such as adrenocortical, parathyroid, and breast carcinomas. However, in other cancer types, such as the multiple endocrine neoplasia syndromes and thyroid cancer, tumor information is limited to candidate genes alone. Future research should fill this gap and deepen our understanding of the functional role of these alterations in cancer, as well as defining their possible clinical uses.
Insights
Epigenetic alterations are common in endocrine tumors, with new technologies revealing genome-wide patterns in some cancers. Further research is needed to understand their role and clinical applications.
Area of Science:
- Oncology
- Epigenetics
- Endocrinology
Background:
- Aberrant epigenetics, including DNA methylation and histone modifications, is a key feature of cancer.
- Endocrine-related tumors exhibit significant epigenetic alterations.
Purpose of the Study:
- To review the current understanding of epigenetic alterations in endocrine tumors.
- To highlight the advancements in identifying these alterations and the gaps in knowledge.
Main Methods:
- Utilized novel microarray and ultra-deep sequencing technologies.
- Analyzed genome-wide epigenetic patterns in specific endocrine tumor types.
Main Results:
- Identified genome-wide epigenetic patterns in adrenocortical, parathyroid, and breast carcinomas.
- Observed limited epigenetic data (candidate genes only) for multiple endocrine neoplasia syndromes and thyroid cancer.
Conclusions:
- Epigenetic alterations are prevalent in endocrine tumors.
- Advanced technologies are crucial for comprehensive epigenetic profiling.
- Further research is required to elucidate the functional roles and clinical utility of these epigenetic changes in endocrine cancers.
More Related Videos
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
11:50Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
Published on: April 3, 2026
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer Prevention
Some...